Examples of 'cabozantinib' in a sentence
Meaning of "cabozantinib"
Cabozantinib is an adjective related to a specific type of cancer treatment medication known as Cabometyx, used for certain types of cancer like kidney cancer or thyroid cancer
Show more definitions
- An experimental drug, so far shown to reduce tumour growth, metastasis, and angiogenesis.
How to use "cabozantinib" in a sentence
Basic
Advanced
cabozantinib
Cabozantinib will be the subject of nine presentations.
There are no studies in pregnant women using cabozantinib.
Effect of cabozantinib on other medicinal products.
Cabometyx contains the active substance cabozantinib.
Cabozantinib is eliminated mainly via the hepatic route.
Severe haemorrhage has been observed with cabozantinib.
Crystalline forms of cabozantinib phosphate and cabozantinib hydrochloride.
Wound complications have been observed with cabozantinib.
Cabozantinib and nivolumab are the preferred.
Latest news on the cabozantinib program.
Cabozantinib should be discontinued in patients who develop nephrotic syndrome.
Hypertension has been observed with cabozantinib.
Cabozantinib is used in two forms.
Proteinuria has been observed with cabozantinib.
The cabozantinib solution was added to the acetic acid solution.
See also
Hemorrhage has been observed with cabozantinib.
The cabozantinib solution was added to the succinic acid slurry.
Fatal perforations have occurred in the cabozantinib clinical program.
Crystalline cabozantinib acetate was obtained.
Urine protein should be monitored regularly during cabozantinib treatment.
Cabozantinib free base is typically used as the starting material.
Fatal haemorrhages have occurred in the cabozantinib clinical program.
Cabozantinib was metabolized in vivo.
Cometriq is a cancer medicine that contains the active substance cabozantinib.
Vandetanib and cabozantinib are used to treat some medullary thyroid cancers.
Women of childbearing potential must be advised to avoid pregnancy while on cabozantinib.
Cabozantinib is a small molecule that inhibits the activity of multiple tyrosine.
Adverse reactions such as fatigue and weakness have been associated with cabozantinib.
Cabozantinib is not yet approved for the treatment of hepatocellular carcinoma.
Female partners of male patients taking cabozantinib must also avoid pregnancy.
Cabozantinib has shown no mutagenic or clastogenic potential in a standard battery of genotoxicity assays.
Formulations of cabozantinib.
The effect of cabozantinib on the pharmacokinetics of contraceptive steroids has not been investigated.
Events of venous thromboembolism and events of arterial thromboembolism have been observed with cabozantinib.
Cabozantinib should not be administered to patients with serious haemorrhage or recent haemoptysis.
The malate salt shows an enhanced solubility when compared with cabozantinib free base.
Crossover from placebo to cabozantinib was not allowed during theblinded treatment phase.
CABOMETYX is the tablet formulation of cabozantinib.
The pharmacokinetics of cabozantinib was not evaluated in patients with severe hepatic impairment.
CABOMETYX is a cancer medicine that contains the active substance cabozantinib.
The cabozantinib free base solution was added to the phosphoric acid solution.
Exelixis holds the exclusive rights to develop and commercialize cabozantinib in the United States.
Cabozantinib should be used with caution in patients with mild or moderate renal impairment.
In case of hypertensive crisis, cabozantinib should be discontinued.
Cabozantinib should be discontinued in patients with wound healing complications requiring medical intervention.
There is little experience with cabozantinib in non-White patients.
Treatment with cabozantinib did require many dose reduction to mitigate side effects.
Blood pressure should be well-controlled prior to initiating cabozantinib.
Cabozantinib should be discontinued in patients who experience ONJ.
In this phase 3 study, participants are treated with either cabozantinib or a placebo.
